124 related articles for article (PubMed ID: 38000679)
21. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
[TBL] [Abstract][Full Text] [Related]
22. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R
Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071
[TBL] [Abstract][Full Text] [Related]
23. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
24. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
Morris CD; Armstrong GR; Bigley G; Green H; Attwood SE
Am J Gastroenterol; 2001 Apr; 96(4):990-6. PubMed ID: 11316217
[TBL] [Abstract][Full Text] [Related]
26. Non-conventional mucosal lesions (serrated epithelial change, villous hypermucinous change) are frequent in patients with inflammatory bowel disease-results of molecular and immunohistochemical single institutional study.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Virchows Arch; 2020 Feb; 476(2):231-241. PubMed ID: 31375911
[TBL] [Abstract][Full Text] [Related]
27. Differential diagnosis of gastric low- and high grade dysplasia using C6orf15 protein.
Liu L; Wang X; He Q; Yu B; Wang J; Shen H
Ann Diagn Pathol; 2024 Aug; 71():152298. PubMed ID: 38547762
[TBL] [Abstract][Full Text] [Related]
28. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.
van Sandick JW; Baak JP; van Lanschot JJ; Polkowski W; ten Kate FJ; Obertop H; Offerhaus GJ
J Pathol; 2000 Feb; 190(2):177-83. PubMed ID: 10657016
[TBL] [Abstract][Full Text] [Related]
29. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma.
Park SY; Jeon SW; Jung MK; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):966-70. PubMed ID: 18787462
[TBL] [Abstract][Full Text] [Related]
31. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
32. Dysplasia discrimination in intestinal-type neoplasia of the esophagus and colon via digital image analysis.
Martin DR; Braxton DR; Farris AB
Virchows Arch; 2016 Oct; 469(4):405-15. PubMed ID: 27492044
[TBL] [Abstract][Full Text] [Related]
33. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
34. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
[TBL] [Abstract][Full Text] [Related]
35. Malignant transformation of gastric hyperplastic polyps: alteration of phenotypes, proliferative activity, and p53 expression.
Yao T; Kajiwara M; Kuroiwa S; Iwashita A; Oya M; Kabashima A; Tsuneyoshi M
Hum Pathol; 2002 Oct; 33(10):1016-22. PubMed ID: 12395375
[TBL] [Abstract][Full Text] [Related]
36. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
[TBL] [Abstract][Full Text] [Related]
37. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
[TBL] [Abstract][Full Text] [Related]
38. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; Lopes C; da Costa-Pereira A; Guilherme M; Barbosa J; Lomba-Viana H; Silva R; Moreira-Dias L
J Clin Pathol; 2004 Feb; 57(2):177-82. PubMed ID: 14747445
[TBL] [Abstract][Full Text] [Related]
39. Radio frequency ablation of dysplastic Barrett's esophagus: Outcomes of a single-center registry.
Mathiesen M; Holm J; Thorsteinsson M
Scand J Surg; 2023 Jun; 112(2):86-90. PubMed ID: 36756673
[TBL] [Abstract][Full Text] [Related]
40. Risk of metachronous gastric neoplasm occurrence during intermediate-term follow-up period after endoscopic submucosal dissection for gastric dysplasia.
Kim YI; Park JY; Kim BJ; Hwang HW; Hong SA; Kim JG
Sci Rep; 2020 Apr; 10(1):6747. PubMed ID: 32317745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
